search
Back to results

Resistance Exercise, Muscle Mass, Strength and Body Composition

Primary Purpose

Sarcopenia, Obesity

Status
Completed
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
HIT-exercise, low repetition range
HIT-exercise, high repetition range
HIT-exercise with protein
Control
Sponsored by
University of Erlangen-Nürnberg Medical School
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sarcopenia focused on measuring resistance exercise, muscle mass, abdominal fat, strength, Coronary Heart Disease (CHD)-risk, myocardial mass

Eligibility Criteria

30 Years - 50 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • males
  • untrained (< 2 h exercise/week, < 1 h resistance exercise/week)
  • 30-50 years old

Exclusion Criteria:

  • medication/diseases affecting intervention or study endpoints
  • history of intense resistance exercise (> 3 h/week during the last decade)
  • very low physical capacity (< 100 Watt at ergometry)
  • more than 2 weeks of absence during the interventional period
  • contraindication related to MRI-assessment (i.e. magnetizable intracorporal artefacts)
  • pathological changes of the heart
  • inflammable diseases

Sites / Locations

  • Institute of Medical Physics, University of Erlangen-Nurnberg

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

HIT-exercise, low repetition range

HIT-exercise, high repetition range

HIT-exercise with protein

Control

Arm Description

High Intensity Resistance Exercise Training, low repetition range, > 75% 1 Repetition Maximum (1RM)

High Intensity Resistance Exercise Training, high repetition range, 60 - <75% 1RM

High Intensity Resistance Exercise Training with protein supplementation

No physical exercise intervention

Outcomes

Primary Outcome Measures

fat free Cross Sectional Area (CSA) upper leg
fat free muscle cross sectional area of the upper leg at mid-femur via Quantitative Computed Tomography (QCT)

Secondary Outcome Measures

CSA upper leg
muscle cross sectional area of the upper leg at mid-femur via QCT

Full Information

First Posted
January 7, 2013
Last Updated
March 20, 2014
Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
Klinikum Nürnberg
search

1. Study Identification

Unique Protocol Identification Number
NCT01766791
Brief Title
Resistance Exercise, Muscle Mass, Strength and Body Composition
Official Title
Effects of Resistance Exercise on Muscle Mass, Strength, Body Composition and Heart in Men 30-50 Years Old.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2014
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
Klinikum Nürnberg

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A plethora of trials reported the positive effect of resistance exercise on functional and morphological parameters. Although a large amount of the studies used suboptimum devices and obsolete methods the results of these older studies were still considered as golden standard. The aim of the present study is thus to determine the proper effect of different resistance exercise protocols with and without adjuvant protein supplementation on functional and morphological muscle and body composition parameters in male untrained subjects 30-50 years old under special regard of modern medical imaging and segmentation technologies. Our general study hypothesis is that HIT-resistance exercise significantly impact relevant muscular parameters of the upper leg.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia, Obesity
Keywords
resistance exercise, muscle mass, abdominal fat, strength, Coronary Heart Disease (CHD)-risk, myocardial mass

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HIT-exercise, low repetition range
Arm Type
Experimental
Arm Description
High Intensity Resistance Exercise Training, low repetition range, > 75% 1 Repetition Maximum (1RM)
Arm Title
HIT-exercise, high repetition range
Arm Type
Experimental
Arm Description
High Intensity Resistance Exercise Training, high repetition range, 60 - <75% 1RM
Arm Title
HIT-exercise with protein
Arm Type
Experimental
Arm Description
High Intensity Resistance Exercise Training with protein supplementation
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
No physical exercise intervention
Intervention Type
Other
Intervention Name(s)
HIT-exercise, low repetition range
Intervention Description
High Intensity Resistance Exercise Training, low repetition range, > 75% 1RM
Intervention Type
Other
Intervention Name(s)
HIT-exercise, high repetition range
Intervention Description
High Intensity Resistance Exercise Training, high repetition range, 60 - < 75 1RM
Intervention Type
Other
Intervention Name(s)
HIT-exercise with protein
Intervention Description
High Intensity Resistance Exercise Training, low repetition range, > 75% 1RM and Protein Supplementation
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
control group, no intervention, maintenance of physical activity
Primary Outcome Measure Information:
Title
fat free Cross Sectional Area (CSA) upper leg
Description
fat free muscle cross sectional area of the upper leg at mid-femur via Quantitative Computed Tomography (QCT)
Time Frame
change from baseline in fat free Cross Sectional Area at 5 months
Secondary Outcome Measure Information:
Title
CSA upper leg
Description
muscle cross sectional area of the upper leg at mid-femur via QCT
Time Frame
change from baseline in CSA upper leg at 5 months
Other Pre-specified Outcome Measures:
Title
intra-abdominal fat mass
Description
intra-abdominal fat mass via Magnetic Resonance Imaging (MRI)
Time Frame
change from baseline in intra-abdominal fat mass at 5 months
Title
maximum strength leg press
Description
Maximum dynamic strength of the leg extensors/-flexors
Time Frame
change from baseline in maximum strength leg press at 5 months
Title
metabolic syndrome score
Description
Metabolic Syndrome Score according to Johnson et al.
Time Frame
change from baseline in metabolic syndrome score at 5 months
Title
myocardial mass/enddiastolic volume
Time Frame
change from baseline in myocardial mass/enddiastolic volume at 5 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: males untrained (< 2 h exercise/week, < 1 h resistance exercise/week) 30-50 years old Exclusion Criteria: medication/diseases affecting intervention or study endpoints history of intense resistance exercise (> 3 h/week during the last decade) very low physical capacity (< 100 Watt at ergometry) more than 2 weeks of absence during the interventional period contraindication related to MRI-assessment (i.e. magnetizable intracorporal artefacts) pathological changes of the heart inflammable diseases
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wolfgang Kemmler, PhD
Organizational Affiliation
University of Erlangen-Nürnberg Medical School
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Andreas Wittke, MA
Organizational Affiliation
University of Erlangen-Nürnberg Medical School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Klaus Engelke, PhD
Organizational Affiliation
University of Erlangen-Nürnberg Medical School
Official's Role
Study Chair
Facility Information:
Facility Name
Institute of Medical Physics, University of Erlangen-Nurnberg
City
Erlangen
ZIP/Postal Code
91052
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
33345059
Citation
Tuttor M, von Stengel S, Kohl M, Lell M, Scharf M, Uder M, Wittke A, Kemmler W. High Intensity Resistance Exercise Training vs. High Intensity (Endurance) Interval Training to Fight Cardiometabolic Risk Factors in Overweight Men 30-50 Years Old. Front Sports Act Living. 2020 Jun 16;2:68. doi: 10.3389/fspor.2020.00068. eCollection 2020.
Results Reference
derived
PubMed Identifier
29216285
Citation
Scharf M, Oezdemir D, Schmid A, Kemmler W, von Stengel S, May MS, Uder M, Lell MM. Myocardial adaption to HI(R)T in previously untrained men with a randomized, longitudinal cardiac MR imaging study (Physical adaptions in Untrained on Strength and Heart trial, PUSH-trial). PLoS One. 2017 Dec 7;12(12):e0189204. doi: 10.1371/journal.pone.0189204. eCollection 2017.
Results Reference
derived

Learn more about this trial

Resistance Exercise, Muscle Mass, Strength and Body Composition

We'll reach out to this number within 24 hrs